Patients and doctors. Health experts and, above all, patients will have a new framework that will help address unmet medical ...
and the European Medicines Agency (EMEA; now EMA). These studies provide data supporting the utility of seven renal biomarkers in safety testing in the preclinical setting. They have now been ...
Both the US Food and Drug Administration (FDA), through the Orphan Drug Act, and the European Medicines Agency (EMA), through ... bodies to have ‘an open and transparent dialogue’ through ...
The move to exit the WHO is historic and controversial. The U.S. has long been the most generous provider of humanitarian ...
MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...
Regulatory sandboxes provide controlled environments for testing digital health innovations, enabling collaboration among ...
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
American scientists would also lose quick access to critical genetic databases run by WHO, which could stall attempts to ...
“The FDA is actively working to develop transparent processes for prioritizing chemicals in food for a safety review as part of the agency’s ... been banned in the European Union, Canada ...